One of these Big Pharma might be doing so to generate cash for a large acquisition. I won't be surprised if we soon hear about a GILD buyout
Sentiment: Strong Buy
Nobody can afford to pony up over $150 billion to buy GILD, slick.
If Pfizer pays 110B for Azn, they can pay for GILD - lot better asset than AZN.
Only Apple, and not sure they want I-Sovaldi lol.
What? $150B? Are you ...